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Abstract 
A rapid and simple Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method has been 
developed for the quantification of Amoxicillin in tablet dosage form. Separation was achieved on Chromatopak-C18 
(250mm×4.6×5micron) column in isocratic mode with mobile phase consisting of Acetonitrile: 0.2M Potassium dihydrogen 
phosphate buffer (pH 3) (22:78v/v) and conditions optimized with flow rate of 1 ml/minute and wavelength of detection at 
283 nm. The retention time of Amoxicillin was found to be 6.4 min. Linearity was established for Amoxicillin in the range 
10 – 100 μg / ml with R
2 
value 0.999. This method was validated in accordance with ICH guidelines, the linearity, accuracy, 
precision, specificity, robustness, ruggedness, and system suitability results were within the acceptance criteria. Validation 
studies demonstrated that the proposed RP-HPLC method is simple, specific, rapid, reliable and reproducible for the 
determination of Amoxicillin for Quality Control level. 
Keywords: RP-HPLC, Amoxicillin, Method Development, Validation. 
 
1. Introduction 
1.1 Amoxicillin 
Amoxicillin is an extended spectrum penicillin 
group of antibiotic. Amoxicillin is active against many 
gram positive and gram negative bacteria. 
Chemical structure 
The molecular formula is C16H19N3O5S•3H2O and 
the molecular weight is 419.45. The chemical structure is: 
 
 
Figure 1: Structure of Amoxicillin 
1.2 Mechanism of action 
Amoxicillin acts by inhibiting bacterial cell wall 
synthesis. Lack of bacterial cell wall results in death due to 
lysis of bacteria. So amoxicillin is useful only for actively 
growing and cell wall synthesizing bacteria. Amoxicillin is 
an extended spectrum, penicillinase-susceptible, semi-
synthetic amino- penicillin. It is a close chemical and 
pharmacological congener of ampicillin (amino-p-hydroxy-
benzyl penicillin). 
Amoxicillin like other penicillins, inhibit the 
penicillin binding proteins (PBPs {specifically PBP-1A}), 
which are transmembrane surface enzymes that catalyse the 
cross linking (transpeptidation) between the peptidoglycans 
in the bacterial cell wall. Amoxicillin is able to bind to the 
PBPs by geometrically mimicking the natural D-alanyl-D-
alanine substrate that is generally bound to the enzyme. By 
substituting itself for D-alanyl-D-alanine, the appropriate 
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strands needed for cross-linking are not available and the 
cell wall biosynthesis process is left incomplete. 
It also acylates the penicillin-sensitive 
transpeptidase C-terminal domain by opening the lactam 
ring. This inactivation of the enzyme prevents the formation 
of a cross-link of two linear peptidoglycan strands, 
inhibiting bacterial cell wall synthesis. Cell lysis is then 
mediated by bacterial cell wall autolytic enzymes such as 
autolysins or murein hydrolases; it is possible that 
amoxicillin interferes with an autolysin inhibitor. [1-6] 
 
2. Materials and Methods 
2.1 Experimental  
2.1.1 Materials  
Tablets containing 125 mg of Amoxicillin was 
obtained from Apollo Pharmaceuticals Pvt. Ltd, Tirupati, 
India and used within their shelf life period. Acetonitrile 
and water (HPLC-grade) were purchased from SD Fine 
Chem. Pvt. Ltd, India. All other chemicals and reagents 
employed were of analytical grade, and purchased from SD 
Fine Chem. Pvt. Ltd, India.  
 
2.1.2 Instrumentation  
Ultrasonicator,0.45μm membrane filter, (PCI 
Analytical, Model Number 1.5L50) Analytical balance 
(Wenser), Analytical Technologies HPLC system, LC 
Solution soft ware having the configurations, Solvent 
degasser DCU-20A3 Solvent degasser, UV-VIS detector 
with class VP software, Columns of Chromatopak-C18 
(250mm×4.6×5micron) were used in this study. A (Eutect) 
digital pH meter was used for pH adjustment. 
 
2.1.3 Chromatographic conditions  
The selected and optimized mobile phase 
composed of Acetonitrile: Potassium dihydrogen phosphate 
buffer (pH 3) (22:78v/v) and conditions optimized were 
with flow rate of 1 ml/minute, wavelength at 283 nm and 
Run time of 20 min. Here the peaks were separated and 
showed better resolution, appreciable theoretical plate 
counts and good peak symmetry. The proposed 
chromatographic conditions were found appropriate for the 
quantitative determination of the present drug  
 
2.1.4 Preparation of mobile phase  
Mobile phase was prepared by taking Acetonitrile: 
0.1 M Potassium di hydrogen phosphate buffer (pH 3) 
(22:78v/v). Mobile phase was filtered through 0.45 μm 
membrane filter and degassed under ultrasonic bath prior to 
use. The mobile phase was pumped through the column at a 
flow rate of 1 ml/min.  
 
2.1.5 Preparation of standard solutions  
Dissolve 30 mg of amoxicillin working standard in 
mobile phase and dilute to 50 ml with the same mobile 
phase. One ml was diluted to 20ml with mobile. Diluted to 
1ml of this solution to 50ml with mobile phase. Finally this 
gave 0.6 ppm solution, then the solution was filtered 
through the 0.45 μm membrane filter and degassed under 
ultrasonic bath prior to use. The solution was injected into 
the HPLC system. 
 
2.1.6 Sample Preparation 
Amoxicillin is available as tablets containing 
125mg of Amoxicillin. Amoxicillin is available in the local 
market with brand names AMOX 125.  Twenty tablets of 
Amoxicillin were taken into a fine powder of the tablets and 
the powder equivalent to 100mg of Amoxicillin was 
weighed accurately and transferred into a 100ml standard 
volumetric flask. The contents were dissolved in buffer and 
sonicated for 30 Minutes. This entire solution was filtered 
through 0.45 micron Whatmann filter paper (No. 41) and 
the final solution was made with mobile phase to get the 
solution of 1000μg/ ml. 1ml of this solution was transferred 
to 10ml volumetric flask, volume was made with 
acetonitrile. It gives 100 µg/ml. 5ml of the solution were 
pipetted out separately into 10ml volumetric flask to give 
10μg/ml concentration. The sample solution 20µl was 
injected and chromatographed.  
 
3. Results and Discussions 
The goal of the present study is to develop and 
validate a simple, accurate and precise ultraviolet 
spectrophotometric method and reversed-phase high-
performance liquid chromatographic (RP-HPLC) for the 
estimation of Amoxicillin in bulk and pharmaceutical 
dosage form. 
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3.1 Experimental trails 
 
Figure 2: Chromatogram of Trial – 1 
 
Trial – 1 was performed on LC, Chromatopak-C18 (250mm×4.6×5micron) column using mobile phase of methanol: water 
in the ratio of 50:50v/v at U.V detection at 267ηm. 
 Result: Broad peaks with some extra peaks were appeared so this was not satisfactory. 
 
Figure 3: Chromatogram of Trial – 2 
 
 Trial – 2 was performed on Chromatopak-C18 (250mm×4.6×5micron) column using mobile phase of Acetonitrile: 
phosphate buffer in the ratio of 95:05 v/v at U.V detection at 283ηm. 
 Fronting with broad peaks and some extra peaks were appeared so this was not satisfactory. 
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Figure 4: Chromatogram of Trial – 3 
 Mobile phase of Acetonitrile: Potassium dihydrogen phosphate buffer adjusted to pH 3 with orthophosphoric acid in the 
ratio of 22:78 v/v at U.V detectection at 283ηm 
 A sharp peak with a retension time of 6.461. 
The trail 3 was selected for the futher work in HPLC as the result was satisfactory with a sharp peak with the 
retension time of 6.461mins 
 
3.2 Method Validation  
The method was validated in accordance with ICH 
guidelines [13]. The parameters assessed were linearity, 
accuracy, and precision, reproducibility, robustness and 
system suitability.  
3.2.1 Accuracy  
Accuracy was best determined by the standard 
addition method. Previously analyzed samples of 
Amoxicillin API were added with standard drug solutions 
and are analyzed by the proposed method. Recovery (%), 
RSD (%) and bias (%) were calculated for each 
concentration.  
Accuracy is reported as percentage bias, which is 
calculated from the expression  
%Bias = (measured value - true value) true value X 100  
3.2.2 Precision  
System precision:  
Standard solution prepared as per test method and 
injected six times and the %RSD value was calculated.  
Method precision:  
Six preparations individually using single batch of 
Amoxicillin drug substance were prepared as per test 
method and injected each solution induplicate on the same 
day in to HPLC. % RSD value was calculated to determine 
intra-day precision.  
3.3 Repeatability 
Table 1: Precision 
Concentration [µg/ml] Peak area 
50 6381711 
50 6272822 
50 6363603 
50 6384644 
50 6385755 
50 6490823 
Area Mean 6379893 
S.D 69419.4 
%R.S.D 1.088 
3.4 Linearity  
Various standards in the range 10-100μg/ml of 
Amoxicillin were injected onto the chromatographic system 
and the peak area was measured. A graph of peak area (on 
Y-axis) versus concentration (on X-axis) is plotted and the 
correlation coefficient was calculated.Table19 gives 
information about the linearity data. From the results, the 
correlation coefficient for Amoxicillin is 0.999 and, it can 
be concluded that the linearity is well within the limit. 
Hence the method is linear. 
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Figure 5: Linearity graph of Amoxicillin 
 
Table 2: Summary of Linearity 
Concentration (μg/ml) Peak Area 
10 735698 
20 1301541 
30 1952312 
40 2603083 
50 3253854 
60 3904625 
80 5206167 
100 6490823 
 
3.5 Accuracy studies 
Table 3: Summary of Accuracy studies 
Spiked level (%) Formulation Conc. (µg/ml) Amount Found % Recovery % Mean recovery SD %RSD 
 
50 
50 79.55 99.45 
99.66 0.599 0.601 50 79.41 99.2 
50 80.27 100.34 
 
100 
50 81.14 101.4 
101.3 0.602 0.594 50 81.57 101.9 
50 80.62 100.7 
 
150 
 
50 79.94 99.92 
100.17 0.296 0.296 50 80.1 100.1 
50 80.42 100.5 
 
The accuracy of the method, recovery studies were 
carried out by adding different amounts (50%, 100% and 
150%) of bulk samples of Amoxicillin within the linearity 
range were taken and added to the pre-analyzed formulation 
of concentration 20µg/ml. From that percentage recovery 
values were calculated. The results were within the range 
and were found to be highly accurate which was shown in 
table 3. 
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Figure 6: Chromatogram of 50% 
 
 
Figure 7: Chromatogram of 100% 
 
3. 6 Limit of Detection and Limit of Quantification 
The LOD and LOQ were calculated based on the 
standard deviation of the response and the slope of the 
constructed calibration curve, as described in International 
Conference on Harmonization guidelines Q2 (R1) was 
shown in table 4. 
Table 4: Summaries of LOD and LOQ 
Parameter Concentration (μg/ml) 
LOD 0.168 
LOQ 0.512 
 
 
3.7 Robustness 
The Robustness of the method was determined by 
making slight changes in the experimental conditions such 
as change in the flow rate, mobile phase and wave length. 
Table 5: Summary of Robustness 
Parameters Condition  %R.S.D RT 
Flow rate  0.9ml/min 0.379 6.450 
Actual flow rate  1ml/min 0.236 6.461            
Flow rate  1.1ml/min 0.22 6.470 
Wavelength  267nm 0.218 6.421 
Wavelength  283nm 0.236 6.461            
Wavelength  276nm 0.258 6.455 
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Figure 8: Chromatogram of Flow rate: 0.9ml/min 
 
Figure 9: Chromatogram of Flow rate: 1.1ml/min 
 
Figure 10: Chromatogram of Flow rate: 1ml/min 
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3.8 System Suitability 
The result of system suitability parameters for Amoxicillin is represented in Table 6 which indicates that all the 
system suitability parameters pass the criteria. 
 
Figure 11: Chromatogram for system suitability 
 
Table 6: Summary of system suitability 
Parameters Amoxicillin 
Retention time (min) 6.461            
Theoretical plates 1199   
HETP 0.014 
Asymmetry 1.1 
 
4. Conclusion 
A simple reverse phase HPLC method was 
developed for the determination of Amoxicillin present in 
pharmaceutical dosage forms. An LC Chromatopak-C18 
(250mm×4.6×5micron) column UV Detector in isocratic 
mode, with mobile phase Acetonitrile: phosphate buffer, pH 
adjusted to 3 with orthophosphoric acid (22:78 v/v) was 
used. The flow rate was 1.0ml/min and effluent was 
monitored at 283ηm. The retention times were 6.4 min for 
Amoxicillin pharmaceutical dosage form. The linearity 
range was found to be 10-100g/ml. The proposed method 
was also validated. The proposed study describes a new RP-
HPLC method for the Estimation of Amoxicillin in 
pharmaceutical dosage form. The method gave good results 
within a short analysis time. The developed method was 
validated in accordance with ICH guidelines and all of the 
results were within the limits. The HPLC method for the 
Estimation of Amoxicillin in tablet dosage form was also 
found to be simple, rapid, precise, accurate and sensitive. A 
good agreement was observed with HPLC method. The 
validated HPLC method can be used for the routine analysis 
of quality control samples. Since the developed method has 
been applied only to a single brand (Amoxicillin 125) the 
same method is applicable to different brands. 
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